Skip to main content
Journal of Multidisciplinary Healthcare logoLink to Journal of Multidisciplinary Healthcare
. 2019 Apr 29;12:299–314. doi: 10.2147/JMDH.S193752

Compliance, adherence, concordance, empowerment, and self-management: five words to manifest a relational maladjustment in diabetes

Salvatore Settineri 1, Fabio Frisone 2,, Emanuele Maria Merlo 2, Daniele Geraci 3, Gabriella Martino 3
PMCID: PMC6499139  PMID: 31118655

Abstract

Background: The pathological reality of diabetes and the incidents in following the prescribed therapies have been considered and are still a serious and relevant problem in the health sector.

Objective: This review aims at highlighting the importance of clinical psychological phenomena that underlie the notion of therapies.

Methods: The review was conducted through search engines such as PubMed, Medline, Web of Science and Google Scholar. The articles related to compliance, adherence, concordance, empowerment and the self-management of diabetes were included, in order to highlight the possible similarities and differences that these terms bring with them in them management of diabetes.

Results: Starting from 252 initial publications, 101 articles were selected that highlighted the practical implications that each term has compared to the others.

Conclusion: The review can represent a bridge between the medical approach and clinical psychology, in which integration can suggest paths aiming at improving patients’ existential conditions and adaptation.

Keywords: compliance, adherence, concordance, empowerment, self-management, diabetes

Introduction

The lack of phenomenological knowledge of the health professional of diabetes, both under the aspect of pharmacology and of physical health, often causes health professionals themselves to forget that the drug has aspects that exceed its biochemical efficacy. We cannot ignore the emotional significance that the patient gives to the drug, and the surplus value that the health professional gives to the therapeutic medium. In this review we will deal with the aspects of collaboration between health professionals and patients that can be seen as effective, or the various proposals by many other authors.17

The educational approach is not sufficient enough, since therapy has a stronger meaning than prescriptions, as suggested by literature.8 This concept is limited to what the patient views as having an active role in their own self-management9,10 or “adherence”.1113 These terms derive from the Latin “adhaerentia”, derivative of adhaerēre “to adhere”, is to be attached, supported, and closed. The use of etymologies and metaphors express only a part of the adjustment processes of the subject. There is in fact a lack between clear instructions given to patients and unknown variables not sufficiently understood, together with low empathy.

It is probably better to use the term “self-care”14 to underline a sort of emotional relationship that is something more than an empathic act. The last cited author suggests an approach to this type of relationship, while suggesting seven behaviors. The same psychoanalyst Jung uses this metaphor: «the meeting of two personalities is like the contact between two chemical substances; if there is a reaction, both are transformed».15

The concept of transference and counter-transference has been emphasized by psychoanalysis. Several other orientations have foreseen further concepts, like Winnicott, who specialized in the field of play and Gestalt in the encounter between patient and therapist. All those theoretical fields, impose on phenomenology as a method of describing the dimension of the phenomenon and the attempt to reach therapeutic protocols that must be adopted to every singular patient. The intent of this research is to highlight the need to get in touch with the subjective experience, in order to improve the outcomes of treatment. The clinical approach ensures a greater likelihood of glycemic control, as proven by the fact that many changes in glycemic metabolism are dictated by the same efforts and styles of health care as Hayes et al16 have taken into account. A frequent mistake made by clinicians is to confuse the prescription and general theoretical orientations of psychology with the subjectivity of a lifestyle. Therefore, there is a necessity to distinguish a prescription from the value that the individual patient attributes to it.

The analysis, although apparently complex and long, arises from the need to highlight the trend of past and current clinical approaches in scientific literature.

Methods

Search strategy

A review of the scientific literature was conducted in order to analyze the behaviors of adherence to the pharmacological treatments of diabetes. Research strategies have been used through the computer database of PubMed, Medline, Web of Science and Google Scholar; the searched keywords refer to the concepts of Compliance, Adherence, Empowerment, Concordance, and Self-Management.

During this phase, the various domains on which the article is focused on have been identified:

  1. Definitions of the phenomena related to the adherence of pharmacological treatments for diabetes;

  2. Intervention strategies and results obtained;

  3. Analysis of current knowledge referring to the origin of non-adherence.

Eligibility

Based on the keywords searched, 252 articles were found, of which 101 selected on the basis of title and abstract. The 101 articles in the table allow us to observe the similarities and differences that characterize the studies that conceptually prefer a term like compliance rather than empowerment or the others to investigate the therapeutic adherence.

Results

Compliance

The meaning of compliance in medicine refers to the ability of an organ to distend in response to applied pressure. In physics, compliance refers to the property of a material undergoing elastic deformation or (of a gas) changing in volume when subjected to an applied force. In therapy, it means to agree with rules or standards. More specifically, the patient and the family’s response to the prescription given.103

In 1997 it was hypothesized that it would be sufficient to reduce the frequency of the doses of the drug to achieve an improvement in compliance; but this practice included risks, as it depended on the therapeutic range of the drug itself.77 Of course, that does not divert from the fact that a better compliance can be achieved by using simpler and less frequent dosage regimens to facilitate the correct intake of drugs.19,30,33,35,39,40,48,51,52,59,61,92,99,102 It is also true that some studies5,10,25,71,72,100,101 have shown that the patient’s motivation to be more compliant with treatment also increases according to the efforts and confidence that the health care provider can transmit in reference to the guidelines to be followed by the patient. The high number of the authors cited underlines the strength of the “trust” element in adhesion to the treatment. Referring to childhood, it has been noted that the complexity related to the treatment of chronic diseases greatly complicates adherence to treatment.44 In order to be able to effectively manage a chronic disease such as diabetes, it seems essential not only to establish a relationship of trust between the health professional and the patient, but also a “friendship”.73 There seems to be a correlation between the quality of an established cooperation and the quality of diabetic treatment. When we talk about the factor of friendship we enter into subjectivity closely linked to the personality of the health professional. The studies on compliance in adolescence6470,88 highlighted that the crucial factor for achieving the best possible treatment depends mainly on the type of relationship that the patient is able to establish with health-care workers, family members and friends. It can be seen from other studies that the importance of the patient-health professional relationship seems to play a decisive role at any age.21,26,38,45,54,57 In light of the above, it seems that in order to achieve an improvement in the patient’s compliance with diabetic care the main solutions are traceable in the possibility of using less painful procedures in taking the required drugs. This is a way of increasing the patient’s knowledge of the chronic disease,29,89,93 while also improving the relationship between the health professional and the patient. Perhaps, the health professional should favor those essential self-care components that Shrivastava summarizes in the seven essential behaviors: healthy eating, being physically active, monitoring blood sugar along with medications, good problem-solving skills, healthy coping skills and risk-reduction behaviors.

Adherence

This term refers to the health professional prescriptions regarding timing, doses, frequency and periods of drugs-consumed.103

From this it is possible to notice how adherence to therapy is defined as the extent to which a person’s behavior in taking medication, following a diet and/or performing changes in lifestyle, corresponds to the recommendations agreed upon by a health professional. Research suggests that adherence to therapeutic recommendations for diabetes treatment is low.96 Producing an effective improvement, could either reduce the risk of complications caused by ineffective treatment or decrease the frustrations of the said health professionals.42

The reasons for non-adherence are multifactorial and difficult to identify. They include age, information, perception and duration of the disease, complexity of the dosage regimen, poly-therapy, cognitive factors, tolerability, clinical inertia, socioeconomic problems, culture, patient education and beliefs, social support and polypharmacy.18,32,43,47,50,82,85,87,97 Those studies also indicate how adherence is implemented through a combination of fixed-dose tablets and less frequent administration regimens, through educational initiatives - with particular attention to the quality of communication between patient and health professional - and through reminders and support systems to help reduce costs. Overall, some results suggest that fixed dose combined tablets and individual dose packaging may improve adherence in a number of settings, but the limitations of available evidence indicate that uncertainty remains about the extent of these benefits.34 Electronic monitoring systems have been useful to improve adherence to individual patients, and could help health professionals to identify patients who need additional support;35 however, even in this case it can be seen how the results obtained cannot completely overcome the problem of adherence.

Figure 2.

Figure 2

The arrow shows how adherence improves treatment. Also in this case the patient maintains a passive role.

Concordance

The term refers to the deep knowledge of the relationship and to the achievability of examining crucial questions regarding the patient’s lifestyle.104

It is important to clarify the dynamics that differentiate the various aspects of the approach to pharmacological therapies in diabetes,20 since the interactive level between clinicians and patients should not be experienced exclusively as an instructive end,21 but as a space for the grouping of skills and support in the decision-making process related to the drug therapy.41 Regarding the terminological transition from compliance to concordance,8 there is a need to overcome the emotion related to rigid orders, to a relationship based on cooperation. It would make the process of taking medicine more stress-free, considering the subject as a decision-maker. The patient’s consideration avoids undergoing orders that place the agents on different levels, and considers both figures of equal breadth.31

Empowerment

This term refers to the strengthening and improvement of power.103

103Empowerment can be considered as a process, in which the contact between an authority and another figure generate improvements in the state of health. There are some studies that suggest setting up structured objectives,56 adapted through problem-solving practices and coping strategies.24,62 The term includes several associated meanings, such as patient-centered and collaborative care but a collaborative approach to clinical reality remains transversal.23 Several scientific contributions tend to emphasize the importance of education in empowerment groups.6,55 However, we cannot help but consider the fact that processes of the over-evaluation of empowerment can produce negligence on other important issues related to the treatment of chronic diseases, as suggested in a review by Paterson.78

Figure 4.

Figure 4

Patient active role with acquisition of competences.

Self-management

This term refers to a system of participative management.103

From a review by Norris et al,2 it emerges that educational self-management and cooperation with patients can be more effective than the exclusive intervention of the health professional, for example glycemic, weight and lipid control. The author reports important scientific contributions that clarify the role of major and minor life events related to self-reported compliance, clarifying that educational intervention can be considered as an indicator of improvement in health status,9 even though it is still unclear how to achieve certain clinical results. It is therefore evident that self-management education produces positive effects, as it is also known that the benefit begins to decline from one to three months after the intervention, suggesting the need to implement practices aimed at promoting them.76 Multi-faceted and organizational interventions that would facilitate structured patient reviews are effective in care pathways.10,80,81

Discussions

The results related to the adherence in the treatment of diabetes highlight a critical fact, because over time the treatment has had different meanings. The Table 1 contains a large number of articles related to the theme; the various articles have posed the problem. Can these terms be used as synonyms or do they need a distinction? In the first analysis the Figures 15 show how the words (compliance, adherence, concordance, empowerment, self-management) empathize the passive or active role of the patient, the exclusive role of the health worker and the synergy of more professionals. The current research involves the collaboration of various figures related to the clinical field; they agree on the need to implement the knowledge of the phenomena related to the failure of adherence. The review of the literature has highlighted how difficult it is to understand the implications of a clinical fact that interfere with the assumption of therapy. Among the elements that lead to these results it would be useful to consider the unconscious aspects of patients. It is noticed that these aspects are dictated by emotions such as desire expressed differently if the patient has a passive role, as shown in Figures 35. It seems interesting to note how all five terms can currently be used according to: a) health education; b) knowledge of the patient; c) level of emotional maturity of the subject; d) personality type; e) value given by the health professional to cognitive and emotional processes; f) life planning; g) availability to knowledge; h) resilience.

Table 1.

Summary table of classification of articles

Reference and year Country/location Purpose Results
Adolfsson et al (2004)6 Sweden Understand what are, according to doctors and nurses, the possible advantages related to strengthening the empowerment process. Doctors and nurses, through the strengthening of the empowerment process, have changed their role from experts to facilitators.
Aronson (2007)17 UK Highlight the conceptual differences of “compliance”, “adherence”, “concordance”. Although “compliance” and “concordance” are sometimes useful, the author suggests that the term “adherence” is the most appropriate one. They pointed out that the standard methods recommended to improve adherence to therapy are often not sufficient to obtain an effective improvement.
Bailey and Kodack (2011)18 UK The review highlights the reasons patients with type 2 diabetes have poor adherence. The reasons for which there is often low adherence refer to several factors, including the lack of good communication and trust in doctor-patient relationships.
Bangalore et al (2007)19 USA Understanding whether a simpler treatment regimen is able to improve compliance. Applying a fixed dose combination should help achieve more satisfactory clinical outcomes.
Bell et al (2007)20 Finland Clarify the conceptual differences between the terms “concordance”, “compliance”, “adherence”. Doctors should be able to develop a method that is more inclined to put the patient at the center of treatment, respecting his rights and building a solid therapeutic alliance.
Bissell et al (2004)21 UK Examine the qualitative interviews of a group of Pakistani patients with type 2 diabetes. The doctor-patient relationship should be used to coordinate the activities of the patients in order to achieve the desired results.
Bissonnette (2008)22 Canada Understand how the terms of adherence, concordance and compliance differ. There is no clear distinction between the terms taken into consideration. Adherence should both ensure a patient-centered medical approach, and suggest the inevitable difference in role that exists between the doctor and the patient.
Boccuzzi et al (2001)1 USA Characterize the patterns of use of the drugs used by prescribers and by the patient. Type 2 diabetes can be managed with different pharmacological modalities, it would be important to be able to find the one most capable of providing satisfactory results.
Bodenheimer et al (2002)23 USA The patient-medical partnership is investigated,involving collaborative assistance and self-managed education. The self-management education for chronic diseases could be extremely important for the treatment.
Bott et al (2000)24 Germany Evaluate how a treatment that takes into account psychosocial dynamics may also be important for treating patients with type 1 diabetes mellitus. Psychosocial aspects also positively influence glycemic control.
Brown (1999)9 USA Understand, through a review of the literature, which are the best interventions for self-management of diabetes. From the literature we note that educating self-management of diabetes allows for better health outcomes.
Bruni et al (2009)25 Italy Understanding whether financial incentives can affect the quality of care. The results of the study argue that financial incentives can help improve the quality of care.
Brunton (2017)26 USA Often, patients do not follow their management plans because of the doctors’ attitude. Medicine has a history of paternalism and a top-down approach in patient care. We need to take time to understand patients concerns and work with them to overcome the obstacles to their treatment. Collaboration with our patients will help us make important progress.
Burge (2001)27 Mexico Since the factors that determine good compliance are not yet known, a study has been carried out to understand which strategies are most effective for good home monitoring. Surely, adopting less painful methods to monitor diabetes could help improve compliance.
Buse et al (2009)28 USA
UK
Italy
Define a cure for diabetes. It is difficult to find a single definition of treatment regarding diabetes.
Chan and Molassiotis (1999)29 Hong Kong Understand how much awareness of diabetes affects good compliance. No relationship between good awareness and good compliance emerged from the research.
Charpentier et al (2005)30 France Compare compliance results with two different types of treatments. The treatment that provided only one daily administration improved compliance compared to that which involved a drug two or three times a day.
Chatterjee (2006)31 Scotland Since compliance also improves compared to the doctor-patient relationship, the term “concordance” can be used. The concept of concordance and what it entails should be more considered in the medical field.
Ciechanowski et al (2000)32 USA Understanding how much depression can affect adherence to drugs and diabetes care. Depressive symptoms greatly affect diabetes care.
Claxton et al (2001)33 USA Understanding how good compliance depends on the frequency of doses. Simpler dosing systems help to achieve good compliance.
Connor et al (2004)34 New Zealand Systematic review to understand if combined fixed-dose and unit-of-use packaging are cheaper to achieve good compliance. Further investigation would be needed to understand the extent of the benefits.
Cramer (2004)35 USA To detect how many times the patients of the study did not take the drugs prescribed for diabetes. Electronic monitoring systems have been useful to improve adherence.
Cramer et al (2004)36 Denmark and USA Understanding whether the AERx® electronic device can help increase compliance. The device seems to provide good results to improve compliance.
Cramer et al (2003)37 Denmark and USA Understanding whether the AERx® iDMS device was a good solution for more accurate glycemic control. The results demonstrate that the AERx® iDMS brings more accurate glycemic control.
Cyrino et al (2009)38 Brazil Highlighting that traditional aspects of diabetes care fail to respond adequately to the challenges of such complex treatment. Empowerment strategies are proposed to help improve diabetes treatment.
Dailey et al (2001)39 USA Understanding which anti-hyperglycemic drugs are best for achieving good compliance. The simplest drug treatment was also the most effective.
Dailey et al (2002)40 USA The persistence and compliance of patients with different regimens of antihyperglycaemic was assessed. Compliance with sulphonylurea or metformin alone was 45% higher than polytherapy.
De las Cuevas (2011)41 Spain Provide a clarification of the terms “Compliance”, “Adherence”, “Concordance”. The concordance could be a parameter to be aimed at. Compliance and adherence are more useful for scientific medical measurements.
Delamater (2006)42 USA The causes of low adherence among patients with diabetes are examined. Greater collaboration between doctor and patient improves adherence.
Donnan et al (2002)43 Scotland Understanding whether the administration of the drug once a day can help to have a better adherence. Taking only one pill a day improves adherence.
Fielding and Duff (1999)44 UK The article examines the progress made over the last 20 years by behavioral research in determining the many factors that influence adherence to treatment. The article suggests how to improve compliance and health results in clinical practice.
Funnell and Anderson (2000)45 USA Evaluating how the patient empowerment process improves compliance. Greater collaboration between doctor and patient helps improve compliance. A redefinition of roles is needed to better address the challenges of diabetes.
Funnell and Anderson (2004)46 USA Find more effective methods for managing chronic diseases. Greater patient involvement in diabetes care intervention strategies delivers effective results.
Gadsby (2002)3 UK Analyze the development of treatments for type 2 diabetes. It will be important not only that the treatment be effective, but also that the behavioral modalities of the doctor are friendly with the patient.
García-Pérez et al (2013)47 Spain Analysis of the factors influencing adherence to the treatment of type 2 diabetes mellitus. Poor adherence is caused by different types of variables that include, among other things, also psychological factors and complexity of the dosage regimen.
Gedawy et al (2017)48 Australia Factors related to oral administration of insulin are investigated Oral administration of insulin could improve patient compliance with diabetes.
Glasgow and Anderson (1999)49 USA The authors have compared the terms “compliance”, “adherence”, “empowerment”, “self-care”, “self-management”. The authors highlight the importance of patient-centered care.
Grant et al (2003)50 USA Evaluate if adherence improves by decreasing the prescribed medications. The study highlights that adherence does not depend on the number of drugs prescribed.
Guillausseau (2003)51 France Evaluate the role played by oral antidiabetic agents. Decreasing the daily administration of drugs increases compliance.
Guillausseau (2005)52 France Investigating whether reducing the frequency of anti-hyperglycemic drugs improves metabolic control. Reducing the frequency of anti-hyperglycaemic drugs could bring great benefits.
Harris (2000)53 USA Check whether the most modern medical care in type 2 diabetes has brought improvements. Compared to current treatment, medical care and patient self-care practices could be improved.
Hayes et al (2008)17 USA Understanding which modalities of intervention could help to obtain better results in the treatment of type 2 diabetes. The modalities of intervention suggested to improve the results for the treatment of diabetes have currently provided heterogeneous results.
Helme and Harrington (2004)54 USA Identify the factors capable of implementing compliance. Results indicate that patient and doctor compliance acquisition strategy has been correlated.
Henshaw (2006)55 UK Investigates the National Service Framework factors that help achieve empowerment for people with diabetes. The quality of the doctor-patient relationship must be taken into account.
Howorka et al (2000)56 Austria Investigate the consequences of a structured insulin treatment instruction. The structured insulin treatment instruction (FIT) has reported numerous benefits, including improved glycemic control.
Ibrahim et al (2010)57 Egypt Evaluate the compliance of patients with diabetes. Low compliance has been shown. educational and training programs are proposed to improve these results.
Ingersoll and Cohen (2008)58 USA Correlations between drug adherence and chronic disease are investigated. The frequency of the dosage and the complexity of the regimen influence adherence.
Istepanian et al (2009)59 UK Evaluate whether mobile telemonitoring can improve glycemic control and blood pressure in patients with diabetes. Mobile telemonitoring offers benefits for treating diabetes.
Jensen et al (2017)60 Denmark Understanding the risk factors of adherence reduction related to the different phases of treatment. Factors that can decrease adherence are different from the treatment phases.
Kardas (2005)61 Poland Understanding whether patients treated with sulfonylureas daily have better compliance than those treated with sulphonylureas twice a day. Patients treated with sulphonylureas daily have better compliance.
Keers et al (2004)62 the Netherlands Determine the effects of the multidisciplinary intensive education program (MIEP) and its influence mechanisms. The MIEP offers advantages for self-managed treatment.
Kennedy-Martin et al (2017)63 UK and USA Explore the published evidence on the costs of health care associated with adherence or persistence of antidiabetic drugs. Non-adherence to the drug increases the costs of health care.
Kyngäs (1999)64 Finland Offer a theoretical model capable of investigating compliance in young people with diabetes. The model seems to offer good results that encourage the creation of a compliance verification tool.
Kyngäs (2000a)65 Finland Understanding the factors that determine compliance in adolescents who have a chronic illness. Good compliance is determined by different types of factors, including a high level of motivation and adequate support from parents, doctors and nurses.
Kyngäs (2000b)66 Finland Analyze the factors that determine good compliance in adolescents with diabetes. Compliance results also depend on the type of support that adolescents receive and on their motivational level.
Kyngäs et al (2000a)67 Finland Understanding, through a literature review, what influences compliance in adolescents who have type 1 diabetes mellitus, chronic asthma, arthritis and epilepsy. What most influences compliance in adolescents is their predisposition to coping with the disease. The levels of compliance also affect the support that parents, doctors and nurses are able to offer adolescents.
Kyngäs and Rissanen (2001)68 Finland Describe the factors that predict compliance in chronic adolescent diseases. The levels of compliance depend greatly on the motivation of adolescents and the support that parents, doctors and nurses can offer.
Kyngäs et al (2000b)69 Finland, USA, and UK Review of the literature on factors influencing compliance in adolescents who have a chronic disease. An adolescent with a chronic illness has more disorders related to emotional well-being. The relationship that adolescents have with family and doctors affects the results of compliance.
Kyngäs et al (1998)70 Finland and UK Understanding the mental representations that adolescents with diabetes have over diabetes care, relationships with doctors, family and friends. Adolescents who perceived disinterested control by doctors, paternalistic relationships from friends, and dominant attitudes on the part of their parents showed low levels of compliance.
Lawler and Viviani (1997)71 USA and Australia Compliance in diabetes care has been evaluated to determine the doctor’s performance. Lack of compliance may indicate deficiencies in the doctor’s knowledge and lack of patient confidence.
Lobach and Hammond (1997)72 USA Determine whether the use of a customized patient management protocol improves compliance. The use of a personalized patient management protocol improves compliance.
Lombardo et al (2005)73 Italy Investigate the compliance of different family groups and recognize the elements that can lead to the health of children and adolescents with insulin-dependent diabetes mellitus. By increasing the quality of cooperation, there will be improvements in the compliance of children and adolescents with insulin-dependent diabetes mellitus.
Lutfey and Wishner (1999)11 USA Understanding how the transition from the concept of “compliance” to the concept of “adherence” can bring improvements. Turning to a more social paradigm to understand patient behavior, professionals can broaden solutions regarding therapeutic adhesion.
McNabb (1997)13 USA Understanding how the patient’s self-care behavior can be measured. The concept of “adeherence” is not sufficient to frame the behavior of “self-care”.
Michie et al (2003)4 UK This review of the research highlights several concepts regarding patient-centered consultations in order to understand if health outcomes differ based on the use of different concepts. It should be investigated through other experimental studies whose concepts based on the patient’s centrality can provide better results for his health.
Moström et al (2017)74 Sweden Examine self-monitoring of blood glucose in people with type 1 diabetes and understand the factors that lead to better adherence. Studies show the importance of using additional glucose monitoring tools.
Mullen (1997)9 USA To show that a terminological change to describe patient compliance produces a change in behavior. With coaching and a non-judgmental attitude from the prescriber, patients are more likely to take the drug.
Nazir et al (2017)75 Pakistan Evaluates the correlation between quality of life as a function of health and compliance with the treatment of patients with type 2 diabetes mellitus. There is no significant correlation between quality of life as a function of health and respect for the treatment of patients with type 2 diabetes mellitus.
Norris et al (2001)2 USA Systematic review of the literature in order to investigate how self-management of type 2 diabetes is adequate. It emerges that especially in the short term the self-management of type 2 diabetes is adequate.
Norris et al (2002)76 USA Understanding whether self-management of type 2 diabetes leads to better results on glycemic control. The advantages offered by self-management education decrease after 1–3 months.
Odegard and Capoccia (2007)7 USA Understand through a systematic review which interventions improve adherence in diabetes. Studies conducted to confirm the main obstacles to adherence of diabetes drugs still appear to be limited.
Paes et al (1997)77 the Netherlands Understanding if dosing frequency affects diabetes compliance. Dose frequency reduction can reduce total non-compliance, but at the same time increases the risk of excessive consumption.
Paterson (2001)78 Canada It investigates the decision-making process of self-care in diabetes. One reason for low compliance is the lack of information that professionals give for diabetes management.
Pladevall et al (2004)79 USA Determine whether measures based on drug exposure of drug adherence are associated with clinical outcomes in patients with diabetes. Further study is needed on the methods for introducing evidence based adherence measures into routine clinical practice and on how to use these measurements to effectively improve adherence and health outcomes in the management of chronic therapy.
Pugh et al (2003)5 USA Evaluate the difference in prescribing models in the years 1997–1999 for patients with type 2 diabetes. The theory of innovation can be a support for the development of more effective projects.
Renders et al (2001)80 the Netherlands, UK, and USA Evaluate whether the interventions aimed at health professionals have contributed to the improvement of diabetes treatment. The interventions aimed at health professionals and the possibility of providing more education to the patient on diabetes management have contributed to the improvement of treatment.
Renders et al (2000)81 the Netherlands, UK, and USA Examine the results obtained from interventions aimed at health professionals to improve the management of patients with diabetes. Patient-centered interventions can offer benefits. The role of nurses is considerable to improve adherence to treatment.
Rosen et al (2003)82 USA Determine if the neuropsychological function is associated with adherence to the prescribed drug. To effectively evaluate patient adherence their neuropsychological functions should be investigated.
Roter et al (1998)83 USA Understanding what interventions occurred between 1977 and 1994 have been more effective in increasing patient compliance. The most effective interventions are those that take into account affective, cognitive and behavioral aspects.
Schaper et al (2017)84 the Netherlands and Denmark Understand what type of drug dosage may be most effective for the treatment of patients with diabetes. A treatment with flexible dosage, able to meet the patient’s requests, that could bring advantages.
Schectman et al (2002)85 USA Evaluate adherence to the treatment of patients with diabetes who have a low income. Specific assistance should be provided for patients with diabetes who have low incomes.
Schilling et al (2002)86 USA Understand the implications regarding the concept of self-management of type 1 diabetes in children and adolescents. It is important to be able to obtain a more precise definition of the concept of self-management.
Shenolikar et al (2006)87 USA Understanding whether adherence to antidiabetic drugs was linked to the ethnic group. Adherence to the antidiabetic drug has been associated with the ethnic group.
Shoemaker et al (2017)88 USA Investigate the factors that lead teens with type 2 diabetes to not comply with the follow-up path. One of the factors that most affects the follow-up phase is the age: younger adolescents are more likely to follow the whole path.
Shrivastava et al (2013)14 India Emphasize the role of physicians in promoting self-care activities in diabetic patients. To improve the self-management of diabetic patients, a systematic and integrated approach must be developed.
Srinivasan et al (2017)89 India Identify the factors that hinder the continuous investigation of diabetic retinopathy in diabetic patients. One of the factors that hinders the control of diabetic retinopathy is the lack of patient awareness of the consequences of this eye condition.
Steinhardt et al (2015)90 USA Evaluate the importance of resilience in the treatment of type 2 diabetes. The RB-DSME is adequate to improve health; a large-scale randomized trial is justified.
Steinhardt et al (2009)91 USA Understanding if the “Diabetes Coaching Program” brings improvements to diabetes self-management. The study shows the effectiveness of the Diabetes Coaching Program on diabetes self-management.
Subramanian et al (2017)92 USA Evaluate strategies that improve preventive diabetes treatment. It is advisable to introduce technological tools within the diabetes prevention program.
Sugiharto et al (2017)10 Indonesia, Taiwan, and Australia Offer nurses an educational program for the treatment of patients with type 2 diabetes. This program has improved the performance of nurses in the treatment of problems with type 2 diabetes.
Sweileh et al (2005)93 Palestine Detect data that shows the level of compliance of patients who have chronic illness. From the data obtained it is necessary to develop further techniques to improve patient compliance.
Tilson (2004)13 USA Analyze health care developments in order to identify the most appropriate terms in the medical journey. The term “adherence” should be used in the patient’s collaborative attitude towards treatment.
Timms and Lowes (1999)94 UK This article provides recommendations for nursing practice related to the treatment of adolescents with diabetes. For adolescents with diabetes, a complex treatment regimen may result in a failure to adhere to the treatment program, which increases the risks for complications related to diabetes in old age.
Toobert et al (2000)95 USA Identify a tool capable of summarizing the self-management activities of diabetes. A questionnaire was found that allows to obtain valid data in reference to self-management of diabetes.
Vermeire et al (2005)96 Belgium and UK Examine the results of interventions on patients with type 2 diabetes mellitus. At present, it does not seem that the proposed interventions have succeeded in improving the adherence of diabetic patients.
Walker and Usher (2003)97 USA Review recent literature on the adult patient regarding diabetes care recommendations. In order to achieve improvements in patient health, diabetes research must be increased.
Wens et al (2004)98 Belgium and UK Show how Cramer’s systematic research does not take into account the important articles in the Embase database. The possibility of facilitating access to databases can help to obtain more satisfying scientific research results.
Winer et al (2005)99 USA Evaluate if a combination therapy can have better results on compliance than a monotherapy. The result shows that the combination therapy gives more results than monotherapy.
Worrall et al (1997)100 UK Evaluate whether family doctors follow the indications provided by the Canadian Diabetes Association. The results show that family doctors offer good care to type 2 diabetic patients.
Zhao et al (2008)101 USA Evaluate whether adults with diabetes follow the American Diabetes Association’s physical activity guidelines. The results show that adults with diabetes have more difficulty following the physical activity program proposed by the American Diabetes Association.
Zhu et al (2017)102 China Evaluate the reliability and validity of cultural adaptation of an instrument that investigates how to manage type 1 diabetes in young patients. The cultural adaptation of the tool offers good validity and reliability.

Figure 1.

Figure 1

The arrow shows the remarkable reduction of HbA1c % in the favourable condition of full compliance, where the patient maintains a passive role.

Figure 5.

Figure 5

Active role of patient with responsibility.

Figure 3.

Figure 3

Patient active role with cooperation.

However, it is not possible to respond hastily to some issues. Is it certain that among the terms “compliance”, “adherence”, “concordance”, “empowerment”, “self-management” a term can bring us closer to the patient’s experience? Is it evident that we can confide with the patient’s experience following the guidelines of one approach instead of another? Is it not true that a chronic pathology like diabetes could, in the long run, provoke a deviation in the subjective perception of the Self?

These questions, rather than discouraging health care, should shift attention from the objective processes of care to the comprehension of each patient. This is close to the phenomenological approach introduced by the German phenomenological tradition.105 In this case, one could easily notice how the quality of the therapeutic proposal, which in self-management would seem to be the best because it activates the conscience in terms of responsibility, in a chronic disease that is so widespread like diabetes it would be effective only in terms of ideals. Since therapy is a path rather than a goal, the idea is to propose a symbolic integration inherent in the very word of self-management. The word Self implies the overcoming of the Ego emphasized in compliance and in adherence, the intellectual overcoming of concordance, the mechanical cognitivism of empowerment.

Conclusions

The vast amount of literature, rather than emphasizing the successes and failures of the treatments, should offer a synthesis based on the complexity that every chronic disease poses. We suggest that the undoubted advantages of multi-disciplinary studies have contributed to a lengthening and improvement in the quality of life. We are faced with a complex phenomenology, which is foreseen by a continuum of damage that goes from the biological lesion to the maladjustment of the subject. The concept of care must be preceded by the promotion of quality of life and prevention policies. Based on the research carried out, a comprehensive need is outlined. We must take into account the resistance and the difficulties of including some aspects within patient care pathways. The valorization and the comprehension of the subjective modalities106 of conducting lifestyle would produce knowledge useful to bring the patient closer to clear indications of the medical prescriptions. The unknown aspects of physical and existential damage107 increase the weight of the phenomenon. The possibility of basing future treatments even on existential knowledge in the scientific field is certainly advantageous. The practical implications of this article refer to the inclusion of existential models of knowledge. The figures involved in this article have helped to suggest that the various points of view can be integrated into the field of care for diabetic patients, in order to turn the research experience into a practical support for patients and their subjective differences. This research aims to suggest an open point of view to the consideration of functional models that provide comprehension.

The peculiarity of the clinical psychology contribution suggests that even for chronic diseases such as diabetes, the mere possibility of listening to the patient could be a valid measure to alleviate the loneliness that aggravates every condition of suffering.108

Disclosure

The authors report no conflicts of interest in this research.

References

  • 1. doi: 10.2337/diacare.24.8.1411. Boccuzzi SJ, Wogen J, Fox J, Sung JC, Shah AB, Kim J. Utilization of oral hypoglycemic agents in a drug-insured US population. Diabetes Care. 2001;24(8):1411–1415. [DOI] [PubMed] [Google Scholar]
  • 2.Norris SL, Engelgau MM, Narayan KV. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care. 2001;24(3):561–587. [DOI] [PubMed] [Google Scholar]
  • 3.Gadsby R. Epidemiology of diabetes. Adv Drug Deliv Rev. 2002;54(9):1165–1172. [DOI] [PubMed] [Google Scholar]
  • 4.Michie S, Miles J, Weinman J. Patient-centredness in chronic illness: what is it and does it matter? Patient Educ Couns. 2003;51(3):197–206. [DOI] [PubMed] [Google Scholar]
  • 5.Pugh MJ, Anderson J, Pogach LM, Berlowitz DR. Differential adoption of pharmacotherapy recommendations for type 2 diabetes by generalists and specialists. Med Care Res Rev. 2003;60(2):178–200. doi: 10.1177/1077558703060002003 [DOI] [PubMed] [Google Scholar]
  • 6.Adolfsson ET, Smide B, Gregeby E, Fernström L, Wikblad K. Implementing empowerment group education in diabetes. Patient Educ Couns. 2004;53(3):319–324. doi: 10.1016/j.pec.2003.07.009 [DOI] [PubMed] [Google Scholar]
  • 7.Odegard PS, Capoccia K. Medication taking and diabetes. Diabetes Educ. 2007;33(6):1014–1029. doi: 10.1177/0145721707308407 [DOI] [PubMed] [Google Scholar]
  • 8.Mullen PD. Compliance becomes concordance. BMJ. 1997;314(7082):691. doi: 10.1136/bmj.314.7082.691 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Brown SA. Interventions to promote diabetes self-management: state of the science. Diabetes Educ. 1999;25(6_suppl):52–61. doi: 10.1177/014572179902500623 [DOI] [PubMed] [Google Scholar]
  • 10.Sugiharto S, Stephenson M, Hsu YY, Fajriyah NN. Diabetes self-management education training for community health center nurses in Indonesia: a best practice implementation project. BI Database System Rev Implement Rep. 2017;15(9):2390–2397. doi: 10.11124/JBISRIR-2016-003329 [DOI] [PubMed] [Google Scholar]
  • 11.Lutfey KE, Wishner WJ. Beyond” compliance” is” adherence”. Improving the prospect of diabetes care. Diabetes Care. 1999;22(4):635–639. [DOI] [PubMed] [Google Scholar]
  • 12.McNabb WL. Adherence in diabetes: can we define it and can we measure it? Diabetes Care. 1997;20(2):215. doi: 10.2337/diacare.20.2.215 [DOI] [PubMed] [Google Scholar]
  • 13.Tilson HH. Adherence or compliance? Changes in terminology. Ann Pharmacother. 2004;38(1):161–162. doi: 10.1345/aph.1D207 [DOI] [PubMed] [Google Scholar]
  • 14.Shrivastava SR, Shrivastava PS, Ramasamy J. Role of self-care in management of diabetes mellitus. J Diabetes Metab Disord. 2013;12(1):14. doi: 10.1186/2251-6581-12-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Jung CG. The Collected Works of CG Jung: Complete Digital Edition. Princeton: Princeton University Press; 2014. [Google Scholar]
  • 16.Hayes E, McCahon C, Panahi MR, Hamre T, Pohlman K. Alliance not compliance: coaching strategies to improve type 2 diabetes outcomes. J Am Acad Nurse Pract. 2008;20(3):155–162. doi: 10.1111/j.1745-7599.2007.00297.x [DOI] [PubMed] [Google Scholar]
  • 17.Aronson JK. Compliance, concordance, adherence. Br J Clin Pharmacol. 2007;63(4):383–384. doi: 10.1111/j.1365-2125.2007.02893.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bailey CJ, Kodack M. Patient adherence to medication requirements for therapy of type 2 diabetes. Int J Clin Pract. 2011;65(3):314–322. doi: 10.1111/j.1742-1241.2010.02544.x [DOI] [PubMed] [Google Scholar]
  • 19.Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713–719. doi: 10.1016/j.amjmed.2006.08.033 [DOI] [PubMed] [Google Scholar]
  • 20.Bell JS, Airaksinen MS, Lyles A, Chen TF, Aslani P. Concordance is not synonymous with compliance or adherence. Br J Clin Pharmacol. 2007;64(5):710–711. doi: 10.1111/j.1365-2125.2007.02971_1.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Bissell P, May CR, Noyce PR. From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc Sci Med. 2004;58(4):851–862. [DOI] [PubMed] [Google Scholar]
  • 22.Bissonnette JM. Adherence: a concept analysis. J Adv Nurs. 2008;63(6):634–643. doi: 10.1111/j.1365-2648.2008.04745.x [DOI] [PubMed] [Google Scholar]
  • 23.Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288(19):2469–2475. [DOI] [PubMed] [Google Scholar]
  • 24.Bott U, Bott S, Hemmann D, Berger M. Evaluation of a holistic treatment and teaching programme for patients with Type 1 diabetes who failed to achieve their therapeutic goals under intensified insulin therapy. Diabet Med. 2000;17(9):635–643. [DOI] [PubMed] [Google Scholar]
  • 25.Bruni ML, Nobilio L, Ugolini C. Economic incentives in general practice: the impact of pay-for-participation and pay-for-compliance programs on diabetes care. Health Policy. 2009;90(2–3):140–148. doi: 10.1016/j.healthpol.2008.09.008 [DOI] [PubMed] [Google Scholar]
  • 26.Brunton S. I have never liked the term “compliance”. Clin Diabetes. 2017;35(2):76–77. doi: 10.2337/cd17-0010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Burge MR. Lack of compliance with home blood glucose monitoring predicts hospitalization in diabetes. Diabetes Care. 2001;24(8):1502–1503. [DOI] [PubMed] [Google Scholar]
  • 28.Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–2135. doi: 10.2337/dc09-9036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Chan YM, Molassiotis A. The relationship between diabetes knowledge and compliance among Chinese with non-insulin dependent diabetes mellitus in Hong Kong. J Adv Nurs. 1999;30(2):431–438. [DOI] [PubMed] [Google Scholar]
  • 30.Charpentier G, Fleury F, Dubroca I, Vaur L, Clerson P. Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance. Diabetes Metab. 2005;31(2):189–195. [DOI] [PubMed] [Google Scholar]
  • 31.Chatterjee JS. From compliance to concordance in diabetes. J Med Ethics. 2006;32(9):507–510. doi: 10.1136/jme.2005.012138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000;160(21):3278–3285. [DOI] [PubMed] [Google Scholar]
  • 33.Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–1310. [DOI] [PubMed] [Google Scholar]
  • 34.Connor J, Rafter N, Rodgers A. Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ. 2004;82:935–939. [PMC free article] [PubMed] [Google Scholar]
  • 35.Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–1224. [DOI] [PubMed] [Google Scholar]
  • 36.Cramer JA, Okikawa J, Bellaire S, Clauson P. Compliance with inhaled insulin treatment using the AERx® iDMS insulin diabetes management system. Diabetes Technol Ther. 2004;6(6):800–807. doi: 10.1089/dia.2004.6.800 [DOI] [PubMed] [Google Scholar]
  • 37.Cramer J, Okikawa J, Clauson P. Compliance with inhaled insulin treatment using AERx® iDMS insulin diabetes management system. Diabetes. 2003;52:A103. [DOI] [PubMed] [Google Scholar]
  • 38.Cyrino AP, Schraiber LB, Teixeira RR. Education for type 2 diabetes mellitus self-care: from compliance to empowerment. Interface (Botucatu). 2009;13(30):93–106. doi: 10.1590/S1414-32832009000300009 [DOI] [Google Scholar]
  • 39.Dailey G, Kim MS, Lian JF. Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus. Clin Ther. 2001;23(8):1311–1320. [DOI] [PubMed] [Google Scholar]
  • 40.Dailey G, Kim MS, Lian JF. Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients. J Int Med Res. 2002;30(1):71–79. doi: 10.1177/147323000203000111 [DOI] [PubMed] [Google Scholar]
  • 41.De las Cuevas C. Towards a clarification of terminology in medicine taking behavior: compliance, adherence and concordance are related although different terms with different uses. Curr Clin Pharmacol. 2011;6(2):74–77. [DOI] [PubMed] [Google Scholar]
  • 42.Delamater AM. Improving patient adherence. Clin Diabetes. 2006;24(2):71–77. doi: 10.2337/diaclin.24.2.71 [DOI] [Google Scholar]
  • 43.Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med. 2002;19(4):279–284. [DOI] [PubMed] [Google Scholar]
  • 44.Fielding D, Duff A. Compliance with treatment protocols: interventions for children with chronic illness. Arch Dis Child. 1999;80(2):196–200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Funnell MM, Anderson RM. The problem with compliance in diabetes. JAMA. 2000;284(13):1709. doi: 10.1001/jama.284.13.1709-JMS1004-6-1 [DOI] [PubMed] [Google Scholar]
  • 46.Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clin Diabetes. 2004;22(3):123–127. doi: 10.2337/diaclin.22.3.123 [DOI] [Google Scholar]
  • 47.García-Pérez LE, Álvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4(2):175–194. doi: 10.1007/s13300-013-0034-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Gedawy A, Martinez J, Al-Salami H, Dass CR. Oral insulin delivery: existing barriers and current counter-strategies. J Pharm Pharmacol. 2018;70(2):197–213. doi: 10.1111/jphp.12852 [DOI] [PubMed] [Google Scholar]
  • 49.Glasgow RE, Anderson RM. In diabetes care, moving from compliance to adherence is not enough. Diabetes Care. 1999;22(12):2090. doi: 10.2337/diacare.22.12.2090 [DOI] [PubMed] [Google Scholar]
  • 50.Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26(5):1408–1412. [DOI] [PubMed] [Google Scholar]
  • 51.Guillausseau PJ. Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes & Metab. 2003;29(1):79–81. doi: 10.1016/S1262-3636(07)70011-3 [DOI] [PubMed] [Google Scholar]
  • 52.Guillausseau PJ. Impact of compliance with oral antihyperglycemic agents on health outcomes in type 2 diabetes mellitus. Treat Endocrinol. 2005;4(3):167–175. [DOI] [PubMed] [Google Scholar]
  • 53.Harris MI. Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care. 2000;23(6):754–758. [DOI] [PubMed] [Google Scholar]
  • 54.Helme DW, Harrington NG. Patient accounts for noncompliance with diabetes self-care regimens and physician compliance-gaining response. Patient Educ Couns. 2004;55(2):281–292. doi: 10.1016/j.pec.2003.10.004 [DOI] [PubMed] [Google Scholar]
  • 55.Henshaw L. Empowerment, diabetes and the national service framework: a systematic review. J Diabetes Nurs. 2006;10(4):128. [Google Scholar]
  • 56.Howorka K, Pumprla J, Wagner-Nosiska D, Grillmayr H, Schlusche C, Schabmann A. Empowering diabetes out-patients with structured education:: short-term and long-term effects of functional insulin treatment on perceived control over diabetes. J Psychosom Res. 2000;48(1):37–44. [DOI] [PubMed] [Google Scholar]
  • 57.Ibrahim NK, Attia SG, Sallam SA, Fetohy EM, El-Sewi F. Physicians’ therapeutic practice and compliance of diabetic patients attending rural primary health care units in Alexandria. J Family Community Med. 2010;17(3):121. doi: 10.4103/1319-1683.74325 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31(3):213–224. doi: 10.1007/s10865-007-9147-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. doi: 10.1109/IEMBS.2009.5334580. Istepanian RS, Sungoor A, Earle KA. Technical and compliance considerations for mobile health self-monitoring of glucose and blood pressure for patients with diabetes. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:5130–5133. [DOI] [PubMed]
  • 60.Jensen ML, Jørgensen ME, Hansen EH, Aagaard L, Carstensen B. Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: the importance of initiation. PLoS One. 2017;12(6):e0179546. doi: 10.1371/journal.pone.0179546 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Kardas P. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes). Diabetes Obes Metab. 2005;7(6):722–728. doi: 10.1111/j.1463-1326.2004.00462.x [DOI] [PubMed] [Google Scholar]
  • 62.Keers JC, Blaauwwiekel EE, Hania M, et al. Diabetes rehabilitation: development and first results of a Multidisciplinary Intensive Education Program for patients with prolonged self-management difficulties. Patient Educ Couns. 2004;52(2):151–157. [DOI] [PubMed] [Google Scholar]
  • 63.Kennedy-Martin T, Boye KS, Peng X. Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient Prefer Adherence. 2017;11:1103. doi: 10.2147/PPA.S134792 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Kyngäs H. A theoretical model of compliance in young diabetics. J Clin Nurs. 1999;8(1):73–80. [DOI] [PubMed] [Google Scholar]
  • 65.Kyngäs H. Compliance of adolescents with chronic disease. J Clin Nurs. 2000;9(4):549–556. [DOI] [PubMed] [Google Scholar]
  • 66.Kyngäs H. Compliance of adolescents with diabetes. J Pediatr Nurs. 2000;15(4):260–267. doi: 10.1053/jpdn.2000.6169 [DOI] [PubMed] [Google Scholar]
  • 67. doi: 10.1016/s1054-139x(99)00042-7. Kyng As HA, Kroll T, Duffy ME. Compliance in adolescents with chronic diseases: a review. J Adolesc Health. 2000;6(26):379–388. [DOI] [PubMed] [Google Scholar]
  • 68.Kyngäs H, Rissanen M. Support as a crucial predictor of good compliance of adolescents with a chronic disease. J Clin Nurs. 2001;10(6):767–774. [DOI] [PubMed] [Google Scholar]
  • 69.Kyngäs H, Duffy ME, Kroll T. Conceptual analysis of compliance. J Clin Nurs. 2000;9(1):5–12. [DOI] [PubMed] [Google Scholar]
  • 70.Kyngäs H, Hentinen M, Barlow JH. Adolescents’ perceptions of physicians, nurses, parents and friends: help or hindrance in compliance with diabetes self-care? J Adv Nurs. 1998;27(4):760–769. [DOI] [PubMed] [Google Scholar]
  • 71.Lawler FH, Viviani N. Patient and physician perspectives regarding treatment of diabetes: compliance with practice guidelines. J Fam Pract. 1997;44(4):369–374. [PubMed] [Google Scholar]
  • 72.Lobach DF, Hammond WE. Computerized decision support based on a clinical practice guideline improves compliance with care standards. Am J Med. 1997;102(1):89–98. [DOI] [PubMed] [Google Scholar]
  • 73.Lombardo F, Salzano G, Messina MF, De Luca F. Compliance and administration methods in management of type 1 diabetes. Acta Biomed. 2005;76(Suppl 3):66–69. [PubMed] [Google Scholar]
  • 74.Moström P, Ahlén E, Imberg H, Hansson PO, Lind M. Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden. BMJ Open Diabetes Res Care. 2017;5(1):e000342. doi: 10.1136/bmjdrc-2016-000342 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Nazir R, Ur S, Azmi Hassali M, Saleem F, Bashir S, Aljadhey H. Does adherence to the therapeutic regimen associate with health related quality of life: findings from an observational study of type 2 diabetes mellitus patients in Pakistan. Pak J Pharm Sci. 2017;30(6):2159–2165. [PubMed] [Google Scholar]
  • 76.Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25(7):1159–1171. [DOI] [PubMed] [Google Scholar]
  • 77.Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care. 1997;20(10):1512–1517. [DOI] [PubMed] [Google Scholar]
  • 78.Paterson B. Myth of empowerment in chronic illness. J Adv Nurs. 2001;34(5):574–581. [DOI] [PubMed] [Google Scholar]
  • 79.Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27(12):2800–2805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Renders CM, Valk GD, Griffin SJ, Wagner EH, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001;24(10):1821–1833. [DOI] [PubMed] [Google Scholar]
  • 81.Renders CM, Valk GD, Griffin SJ, Wagner E, van Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev. 2000;(4). doi: 10.1002/14651858.CD001481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Rosen MI, Beauvais JE, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Neuropsychological correlates of suboptimal adherence to metformin. J Behav Med. 2003;26(4):349–360. [DOI] [PubMed] [Google Scholar]
  • 83.Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;1138–1161. doi: 10.1097/00005650-199808000-00004 [DOI] [PubMed] [Google Scholar]
  • 84.Schaper NC, Nikolajsen A, Sandberg A, Buchs S, Bøgelund M. Timing of insulin injections, adherence, and glycemic control in a multinational sample of people with type 2 diabetes: a cross-sectional analysis. Diabetes Ther. 2017;8(6):1319–1329. doi: 10.1007/s13300-017-0317-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25(6):1015–1021. [DOI] [PubMed] [Google Scholar]
  • 86.Schilling LS, Grey M, Knafl KA. The concept of self-management of type 1 diabetes in children and adolescents: an evolutionary concept analysis. J Adv Nurs. 2002;37(1):87–99. [DOI] [PubMed] [Google Scholar]
  • 87.Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT. Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc. 2006;98(7):1071. [PMC free article] [PubMed] [Google Scholar]
  • 88.Shoemaker A, Cheng P, Gal RL, et al. Predictors of loss to follow-up among children with type 2 diabetes. Horm Res Paediatr. 2017;87(6):377–384. doi: 10.1159/000475595 [DOI] [PubMed] [Google Scholar]
  • 89.Srinivasan NK, John D, Rebekah G, Kujur ES, Paul P, John SS. Diabetes and diabetic retinopathy: knowledge, attitude, practice (KAP) among diabetic patients in a tertiary eye care centre. J Clin Diagn Res. 2017;11(7):NC01. doi: 10.7860/JCDR/2017/24731.9963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Steinhardt MA, Brown SA, Dubois SK, Jr L H, Lehrer HM, Jaggars SS. A resilience intervention in African-American adults with type 2 diabetes. Am J Health Behav. 2015;39(4):507–518. doi: 10.5993/AJHB.39.4.7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Steinhardt MA, Mamerow MM, Brown SA, Jolly CA. A resilience intervention in African American adults with type 2 diabetes. Diabetes Educ. 2009;35(2):274–284. doi: 10.1177/0145721708329698 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Subramanian K, Midha I, Chelapilla V. Overcoming the challenges in implementing type 2 diabetes mellitus prevention programs can decrease the burden on healthcare costs in the United States. J Diabetes Res 2017;2017:2615681. [Google Scholar]
  • 93.Sweileh W, Aker O, Hamooz S. Rate of compliance among patients with diabetes mellitus and hypertension. An-Najah Univ J Res (N Sci). 2005;19:1. [Google Scholar]
  • 94.Timms N, Lowes L. Autonomy or non-compliance in adolescent diabetes? Br J Nurs. 1999;8(12):794–800. doi: 10.12968/bjon.1999.8.12.6574 [DOI] [PubMed] [Google Scholar]
  • 95.Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–950. [DOI] [PubMed] [Google Scholar]
  • 96.Vermeire EI, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;(2). doi: 10.1002/14651858.CD003638.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Walker EA, Usher JA. Understanding and enhancing adherence in adults with diabetes. Curr Diab Rep. 2003;3(2):141–148. [DOI] [PubMed] [Google Scholar]
  • 98.Wens J, Vermeire E, Van Royen P, Hearnshaw H. A systematic review of adherence with medications for diabetes (Letter). Diabetes Care. 2004;27:2284. doi: 10.2337/diacare.27.9.2284 [DOI] [PubMed] [Google Scholar]
  • 99.Winer N, Folker A, Murphy JA, et al. Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes. Prev Cardiol. 2005;8(2):87–92. [DOI] [PubMed] [Google Scholar]
  • 100.Worrall G, Freake D, Kelland J, Pickle A, Kennan T. Care of patients with type II diabetes: a study of family physicians’ compliance with clinical practice guidelines. J Fam Pract. 1997;44(4):374–382. [PubMed] [Google Scholar]
  • 101.Zhao G, Ford ES, Li C, Mokdad AH. Compliance with physical activity recommendations in US adults with diabetes. Diabet Med. 2008;25(2):221–227. doi: 10.1111/j.1464-5491.2007.02332.x [DOI] [PubMed] [Google Scholar]
  • 102.Zhu J, Xu J, Chen Y, et al. Cross-cultural adaption and psychometric properties of the Chinese version of the Diabetes Behavior Rating Scale: a pilot study. Sci China Life Sci. 2018;61(3):310–317. doi: 10.1007/s11427-016-9070-7 [DOI] [PubMed] [Google Scholar]
  • 103.Oxford English Dictionary; 2008. Available from: http://www.oed.com/;jsessionid=1C35C24E059AA7EBBA0BBD226D04B997?showLogin=false. Accessed May30, 2008.
  • 104.Manfredi P. La concordanza nel rapporto medico-paziente e la formazione medica [Concordance in the doctor-patient relationship and medical training]. MEDIC. 2016;24(2):58–63. Italian. [Google Scholar]
  • 105.Jaspers K. Allgemeine Psychopathologie. Berlin: Springer; 1959 [1913]. (trad. it. di R. Priori, Psicopatologia generale, Il pensiero Scientifico Editore, Roma 1964). [Google Scholar]
  • 106.Langher V, Caputo A, Martino G. What happened to the clinical approach to case study in psychological research? A clinical psychological analysis of scientific articles in high impact-factor journals. Mediterr J Clin Psychol 2017;5(3). [Google Scholar]
  • 107.Marchini F, Caputo A, Napoli A, Balonan JT, Martino G, Nannini V, Langher V. Chronic illness as loss of good self: underlying mechanisms affecting diabetes adaptation. Mediterr J Clin Psychol 2018. Dec 20;6(3):1–16. [Google Scholar]
  • 108.Borgna E, ed. Malinconia [Melancholy]. Milan: Universale Economica Feltrinelli/Saggi; 2001. Italian. [Google Scholar]

Articles from Journal of Multidisciplinary Healthcare are provided here courtesy of Dove Press

RESOURCES